Literature DB >> 22335602

Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective α-melanocyte-stimulating hormone (α-MSH) analogues.

Kilian Conde-Frieboes1, Henning Thøgersen, Jesper F Lau, Ulrich Sensfuss, Thomas K Hansen, Leif Christensen, Jane Spetzler, Helle B Olsen, Cecilia Nilsson, Kirsten Raun, Kirsten Dahl, Birgit S Hansen, Birgitte S Wulff.   

Abstract

We report in vitro and in vivo data of new α-melanocyte-stimulating hormone (α-MSH) analogues which are N-terminal modified with a long chain fatty acid derivative. While keeping the pharmacophoric motif (d-Phe-Arg-Trp) fixed, we tried to improve selectivity and physicochemical parameters like solubility and stability of these analogues by replacing amino acids further away from the motif. Receptor specific changes in binding affinity to the melanocortin receptors were observed between the acetyl derivatives and the fatty acid analogues. Furthermore, amino acids at the N-terminal of α-MSH (Ser-Tyr-Ser) not considered to be part of the pharmacophore were found to have an influence on the MC4/MC1 receptor selectivity. While the acetyl analogues have an in vivo effect for around 7 h, the long chain fatty acid analogues have an effect up to 48 h in an acute feeding study in male Sprague-Dawley rats after a single subcutaneous administration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22335602     DOI: 10.1021/jm201489a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Biphasic effect of melanocortin agonists on metabolic rate and body temperature.

Authors:  Beth Lute; William Jou; Dalya M Lateef; Margalit Goldgof; Cuiying Xiao; Ramón A Piñol; Alexxai V Kravitz; Nicole R Miller; Yuning George Huang; Clemence Girardet; Andrew A Butler; Oksana Gavrilova; Marc L Reitman
Journal:  Cell Metab       Date:  2014-06-26       Impact factor: 27.287

Review 2.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

Review 3.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

4.  Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.

Authors:  Rasmus Eliasen; Norelle L Daly; Birgitte S Wulff; Thomas L Andresen; Kilian W Conde-Frieboes; David J Craik
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 5.  Derivatization with fatty acids in peptide and protein drug discovery.

Authors:  Peter Kurtzhals; Søren Østergaard; Erica Nishimura; Thomas Kjeldsen
Journal:  Nat Rev Drug Discov       Date:  2022-08-24       Impact factor: 112.288

Review 6.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

Review 7.  Brain delivery of proteins via their fatty acid and block copolymer modifications.

Authors:  Xiang Yi; Alexander V Kabanov
Journal:  J Drug Target       Date:  2013-12       Impact factor: 5.121

8.  G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.

Authors:  Masoud Ghamari-Langroudi; Gregory J Digby; Julien A Sebag; Glenn L Millhauser; Rafael Palomino; Robert Matthews; Taneisha Gillyard; Brandon L Panaro; Iain R Tough; Helen M Cox; Jerod S Denton; Roger D Cone
Journal:  Nature       Date:  2015-01-19       Impact factor: 49.962

9.  Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity.

Authors:  Keld Fosgerau; Kirsten Raun; Cecilia Nilsson; Kirsten Dahl; Birgitte S Wulff
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

10.  Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects.

Authors:  Jane E Royalty; Gitte Konradsen; Ole Eskerod; Birgitte S Wulff; Birgit S Hansen
Journal:  J Clin Pharmacol       Date:  2013-11-19       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.